Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2025-12-24 @ 10:54 PM
NCT ID:
NCT00795769
Eligibility Criteria:
Inclusion
* Autologous PBSC transplant patient
* English-speaking
* Planned cryopreserved PBSC infusion at the SCCA outpatient clinic
Exclusion
* History of prior autologous transplant
* Non-English-speaking
* Planned cryopreserved PBSC infusion at the UWMC inpatient unit
* Infusion of cryopreserved PBSC that are thawed and washed to remove DMSO prior to infusion
* Allergy or adverse reaction to ondansetron
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT00795769
Study Brief:
Protocol Section:
NCT00795769